SlideShare a Scribd company logo
Chronic Kidney Disease
HIMANI
GROUP-18
18 FEB 2023
Outline
• Define Chronic Kidney Disease.
• Briefly discuss it’s pathophysiology, epidemiology, and risk
factors.
• Discuss the role of genetics in Chronic Kidney Disease.
• Look at relationship between the UMOD gene and MMP20
gene with chronic kidney disease.
• Assess how these genes affect the risk and diagnosis of
Chronic Kidney Disease.
• What knowledge would a physician and patient want to know
to understand how their genotype affects their risk for
developing chronic kidney disease.
What is CKD?
Chronic Kidney Disease is defined as a slow lose
of renal function over time. This leads to a
decreased ability to remove waste products
from the body and perform homeostatic
functions.
Clinical Definition
• GFR of less than 60 ml/minute per 1.73m2 per body
surface area (normal is 125ml/min) .
– GFR Calculator:
http://www.kidney.org/professionals/kdoqi/gfr_calculator.
cfm
• Presence of kidney damage, regardless of the cause,
for three or more months
Epidemiology
• CKD affects about 26 million people in the US
• Approximately 19 million adults are in the
early stages of the disease
– On the rise do to increasing prevalence of diabetes
and hypertension
• Total cost of ESRD in US was approximately
$40 billion in 2008
Pathophysiology
• Repeated injury to kidney
Symptoms
• Hematuria
• Flank pain
• Edema
• Hypertension
• Signs of uremia
• Lethargy and fatigue
• Loss of appetite
• If asymptomatic may have elevated serum
creatinine concentration or an abnormal
urinalysis
Risk Factors
• Age of more than 60 years
• Hypertension and Diabetes
– Responsible for 2/3 of cases
• Cardiovascular disease
• Family history of the disease.
• Race and ethnicity
• Highest incidence is for African Americans
• Hispanics have higher incidence rates of ESRD than non-
Hispanics.
Convergence of Genetic Factors
• Genes for heart and vascular disease
• Genes that maintain ionic balance
• Genes for glomerulonephritis
• Genes for diabetes
• Genes that may be involved in inherited renal diseases
Genetics of CKD
• Markers of kidney function found to be 27-33%
heritable.
• Serum creatinine, GFR, albumin, proteinuria, BUN
• Many genes associated with chronic kidney
disease:
• APOL1 in African Americans
• UMOD
• SHROOM3
• GATM-SPATA5L1
• MMP20
• MPPED2, DDX1, CDK12, CASP9, and INO80
• LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA,
PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2, and SLC7A9N
Genes Looked At
• UMOD gene
– Encodes urodoulin protein.
– Function unknown but thought to be involved
immunologically.
– UMOD is transcribed exclusively in renal tubular cells of the
thick ascending limb of the loop of Henle.
• MMP20
– Encodes a member of the matrix metalloproteinase family,
which are involved in the breakdown of extracellular matrix
in normal physiological processes.
– MMP20 degrades amelogenin, found mostly in tooth
enamel.
– MMP20 recently implicated to be associated with kidney
disease aging.
UMOD Gene
SNP Ancestral
Allele
Variant
Allele
Odds
Ratio
p-value Significance
rs4293393 T C 0.76
(also
reported
as 1.25)
p-=.001
(also
reported as
4.1x10-10)
Associated with autosomal
dominant forms of kidney disease,
medullary cystic kidney disease
type 2, and familial juvenile
hyperuricemic nephropathy. C
allele protective.
rs13333226 G A 0.87 3.6x10-11 Presence of G allele is associated
with better renal function.
rs12917707 G T 0.80 2x10-12 Presence of T is associated with
20% decreased risk of CKD.
MMP20 Gene
SNP Ancestral
Allele
Variant
Allele
Odds
Ratio
p-value Significance
rs1711437 G A P-value
=3.6x10-5
Associated with kidney ageing.
Only explains 1-2% of variance in
GFR.
Risk Translated
• Average population risk for chronic kidney disease is 3.4%
• In people with rs4293393-T, serum creatinine increases faster
with age (especially over the age of 50), and with comorbid
conditions such as hypertension and diabetes.
• In people with rs13333226-G, is associated with a slightly lower
risk of hypertension and a 7.7% reduction per allele for risk of CV
events.
• In people with rs12917707-T, we see a 20% decreased risk of CKD
• In people with rs1711437-A, their creatinine clearance is
approximately that of someone who is 4–5 years younger.
What Should Patients and Doctors Know
• In general CKD is characterized by a gradual loss of
the kidney’s filtration capacity.
• Markers Don’t tell everything
– Genetic variants found so far only account for 1.4% of
variance seen in eGFR, and at most the relative risk for CKD
is modified by 20% per loci.
What Should Patients and Doctors Know
• Genetic Risk does not translate into clinical risk
– Complex interaction with environmental factors
– Would need to calculate a likelihood ratio in
conjunction with a probability of disease
prevalence to gain a better estimate of clinical risk.
What Should Patients and Doctors Know
• Prevention
– Keep diabetes and blood pressure controlled
– If at risk perform screening tests
– Reduce exposure to nephrotoxic drugs
– Eat right and exercise
– Know your family history
• If you have a positive family history ask doctor to
perform common screening tests for kidney function.
TREATMENT
• High blood pressure medications. People with kidney disease can have worsening high blood
• pressure. Your doctor might recommend medications to lower your blood pressure —
• commonly
• angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers — and to
• preserve kidney function.
High blood pressure medications can initially decrease kidney function and change electrolyte
• levels, so you might need frequent blood tests to monitor your condition. Your doctor may also
• recommend
• a water pill (diuretic) and a low-salt diet.
• Medications to relieve swelling. People with chronic kidney disease often retain fluids. This can
• lead
• to swelling in the legs as well .as high blood pressure. Medications called diuretics can help
• maintain
• the balance of fluids in your body.
• Medications to treat anemia. Supplements of the hormone erythropoietin , sometimes with
• added iron,
• help produce more red blood cells. This might relieve fatigue and weakness associated with
• anemia.
• Medications to lower cholesterol levels. Your doctor might recommend medications called
• statins to
• lower your cholesterol. People with chronic kidney disease often have high levels of bad
• cholesterol,
• which can increase the risk of heart disease
Treatment for end-stage kidney disease
If your kidneys can't keep up with waste and fluid clearance on their own and you develop complete or near-comple
• Dialysis. Dialysis artificially removes waste products and extra fluid from your blood when your kidneys can n
• longer do this. In hemodialysis, a machine filters waste and excess fluids from your blood.
In peritoneal dialysis, a thin tube inserted into your abdomen fills your abdominal cavity with a dialysis
• solution
• that absorbs waste and excess fluids. After a time, the dialysis solution drains from your body, carrying the w
• with it.
• Kidney transplant. A kidney transplant involves surgically placing a healthy kidney from a donor into your
• body. Transplanted kidneys can come from deceased or living donors.
• Medications to protect your bones. Calcium and vitamin D supplements can help prevent weak bones and lo
• your risk of fracture. You might also take medication known as a phosphate binder to lower the amount of
• phosphate in your blood and protect your blood vessels from damage by calcium deposits (calcification).
• A lower protein diet to minimize waste products in your blood. As your body processes protein from
• foods,
• it creates waste products that your kidneys must filter from your blood. To reduce the amount of work your kidn
• must do, your doctor might recommend eating less protein. A registered dietitian can suggest ways to lower yo
• protein intake while still eating a healthy diet
Sources
• Wheeler et al 2009. Sequential Use of Transcriptional
Profiling, Expression Quantitative Trait Mapping, and Gene
Association ImplicatesMMP20 in Human Kidney Aging.
• Padmanabhan S et al. (2010) . “Genome-wide association
study of blood pressure extremes identifies variant near
UMOD associated with hypertension.”PLoS
Genet. 6(10):e1001177.
• Gudbjartsson DF et al. (2010) . “Association of variants at
UMOD with chronic kidney disease and kidney stones-role of
age and comorbid diseases.” PLoS Genet. 6(7):e1001039.
• Köttgen A et al. (2009) . “Multiple loci associated with
indices of renal function and chronic kidney disease.” Nat.
Genet. 41(6):712-7.

More Related Content

Similar to CKD Presentation1 2.pptx

Approach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptxApproach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptx
imrulsujon1
 

Similar to CKD Presentation1 2.pptx (20)

Ckd prevention
Ckd preventionCkd prevention
Ckd prevention
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
Renal failure
Renal failureRenal failure
Renal failure
 
CKD(1).pptx
CKD(1).pptxCKD(1).pptx
CKD(1).pptx
 
Ckd and the family physician
Ckd and the family physicianCkd and the family physician
Ckd and the family physician
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)Chronic Renal Failure (End Stage Renal Failure)
Chronic Renal Failure (End Stage Renal Failure)
 
A Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney DiseaseA Case Presentation on Chronic Kidney Disease
A Case Presentation on Chronic Kidney Disease
 
ANEMIA IN DIABETES MELLITUS
ANEMIA IN DIABETES MELLITUSANEMIA IN DIABETES MELLITUS
ANEMIA IN DIABETES MELLITUS
 
chronic kidney disease.pptx
chronic kidney disease.pptxchronic kidney disease.pptx
chronic kidney disease.pptx
 
Chapter 6 Endocrine disorders by Dr. Derejepdf
Chapter 6 Endocrine disorders by Dr. DerejepdfChapter 6 Endocrine disorders by Dr. Derejepdf
Chapter 6 Endocrine disorders by Dr. Derejepdf
 
Cirrhosis of liver
Cirrhosis of liverCirrhosis of liver
Cirrhosis of liver
 
Global Medical Cures™ | High Blood Pressure and Kidney Disease
Global Medical Cures™ | High Blood Pressure and Kidney DiseaseGlobal Medical Cures™ | High Blood Pressure and Kidney Disease
Global Medical Cures™ | High Blood Pressure and Kidney Disease
 
Approach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptxApproach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptx
 
MCDP_Renal.pdf
MCDP_Renal.pdfMCDP_Renal.pdf
MCDP_Renal.pdf
 
AKI & CKD for DCM-converted.pdf
AKI & CKD for DCM-converted.pdfAKI & CKD for DCM-converted.pdf
AKI & CKD for DCM-converted.pdf
 
Chronic Kidney Disease -Dhaval Joshi
Chronic Kidney Disease -Dhaval JoshiChronic Kidney Disease -Dhaval Joshi
Chronic Kidney Disease -Dhaval Joshi
 
Management of chronic kidney disease
Management of chronic kidney diseaseManagement of chronic kidney disease
Management of chronic kidney disease
 
Chronic kidney disease in childhood
Chronic kidney disease in childhoodChronic kidney disease in childhood
Chronic kidney disease in childhood
 
metabolic dysfunction associated steatotic liver disease.pptx
metabolic dysfunction associated steatotic liver disease.pptxmetabolic dysfunction associated steatotic liver disease.pptx
metabolic dysfunction associated steatotic liver disease.pptx
 

Recently uploaded

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
ananyagirishbabu1
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Benefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptxBenefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptx
Dentulu Inc
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
ASKatoch1
 

Recently uploaded (20)

Mental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck PresentationMental Health Startup Pitch Deck Presentation
Mental Health Startup Pitch Deck Presentation
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
Chris Shade BS MEd MS LPC-Associate "Presume" (What Do I Do?)
 
Valle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder AbuseValle Egypt Illustrates Consequences of Financial Elder Abuse
Valle Egypt Illustrates Consequences of Financial Elder Abuse
 
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
Cell structure slideshare.pptx Unlocking the Secrets of Cells: Structure, Fun...
 
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdfCHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
CHAPTER- 1 SEMESTER V NATIONAL-POLICIES-AND-LEGISLATION.pdf
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
Benefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptxBenefits of Dentulu's Salivary Testing.pptx
Benefits of Dentulu's Salivary Testing.pptx
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
Call Girls in Jaipur (Rajasthan) call me [🔝89011-83002🔝] Escort In Jaipur ℂal...
Call Girls in Jaipur (Rajasthan) call me [🔝89011-83002🔝] Escort In Jaipur ℂal...Call Girls in Jaipur (Rajasthan) call me [🔝89011-83002🔝] Escort In Jaipur ℂal...
Call Girls in Jaipur (Rajasthan) call me [🔝89011-83002🔝] Escort In Jaipur ℂal...
 
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdfSugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
Sugar Medicine_ Natural Homeopathy Remedies for Blood Sugar Management.pdf
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docx
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
 
The Docs PPG - 30.01.2024.pptx..........
The Docs PPG - 30.01.2024.pptx..........The Docs PPG - 30.01.2024.pptx..........
The Docs PPG - 30.01.2024.pptx..........
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
 
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts  by ✔️🍑💃Hotel #cALL #gIRLS...
💃Joint ❤89011-83002❤ #ℂALL #gIRLS Ludhiana Escorts by ✔️🍑💃Hotel #cALL #gIRLS...
 
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
#cALL# #gIRLS# In Chhattisgarh ꧁❤8901183002❤꧂#cALL# #gIRLS# Service In Chhatt...
 

CKD Presentation1 2.pptx

  • 2. Outline • Define Chronic Kidney Disease. • Briefly discuss it’s pathophysiology, epidemiology, and risk factors. • Discuss the role of genetics in Chronic Kidney Disease. • Look at relationship between the UMOD gene and MMP20 gene with chronic kidney disease. • Assess how these genes affect the risk and diagnosis of Chronic Kidney Disease. • What knowledge would a physician and patient want to know to understand how their genotype affects their risk for developing chronic kidney disease.
  • 3. What is CKD? Chronic Kidney Disease is defined as a slow lose of renal function over time. This leads to a decreased ability to remove waste products from the body and perform homeostatic functions.
  • 4. Clinical Definition • GFR of less than 60 ml/minute per 1.73m2 per body surface area (normal is 125ml/min) . – GFR Calculator: http://www.kidney.org/professionals/kdoqi/gfr_calculator. cfm • Presence of kidney damage, regardless of the cause, for three or more months
  • 5.
  • 6. Epidemiology • CKD affects about 26 million people in the US • Approximately 19 million adults are in the early stages of the disease – On the rise do to increasing prevalence of diabetes and hypertension • Total cost of ESRD in US was approximately $40 billion in 2008
  • 8. Symptoms • Hematuria • Flank pain • Edema • Hypertension • Signs of uremia • Lethargy and fatigue • Loss of appetite • If asymptomatic may have elevated serum creatinine concentration or an abnormal urinalysis
  • 9. Risk Factors • Age of more than 60 years • Hypertension and Diabetes – Responsible for 2/3 of cases • Cardiovascular disease • Family history of the disease. • Race and ethnicity • Highest incidence is for African Americans • Hispanics have higher incidence rates of ESRD than non- Hispanics.
  • 10. Convergence of Genetic Factors • Genes for heart and vascular disease • Genes that maintain ionic balance • Genes for glomerulonephritis • Genes for diabetes • Genes that may be involved in inherited renal diseases
  • 11. Genetics of CKD • Markers of kidney function found to be 27-33% heritable. • Serum creatinine, GFR, albumin, proteinuria, BUN • Many genes associated with chronic kidney disease: • APOL1 in African Americans • UMOD • SHROOM3 • GATM-SPATA5L1 • MMP20 • MPPED2, DDX1, CDK12, CASP9, and INO80 • LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA, PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2, and SLC7A9N
  • 12. Genes Looked At • UMOD gene – Encodes urodoulin protein. – Function unknown but thought to be involved immunologically. – UMOD is transcribed exclusively in renal tubular cells of the thick ascending limb of the loop of Henle. • MMP20 – Encodes a member of the matrix metalloproteinase family, which are involved in the breakdown of extracellular matrix in normal physiological processes. – MMP20 degrades amelogenin, found mostly in tooth enamel. – MMP20 recently implicated to be associated with kidney disease aging.
  • 13. UMOD Gene SNP Ancestral Allele Variant Allele Odds Ratio p-value Significance rs4293393 T C 0.76 (also reported as 1.25) p-=.001 (also reported as 4.1x10-10) Associated with autosomal dominant forms of kidney disease, medullary cystic kidney disease type 2, and familial juvenile hyperuricemic nephropathy. C allele protective. rs13333226 G A 0.87 3.6x10-11 Presence of G allele is associated with better renal function. rs12917707 G T 0.80 2x10-12 Presence of T is associated with 20% decreased risk of CKD.
  • 14. MMP20 Gene SNP Ancestral Allele Variant Allele Odds Ratio p-value Significance rs1711437 G A P-value =3.6x10-5 Associated with kidney ageing. Only explains 1-2% of variance in GFR.
  • 15. Risk Translated • Average population risk for chronic kidney disease is 3.4% • In people with rs4293393-T, serum creatinine increases faster with age (especially over the age of 50), and with comorbid conditions such as hypertension and diabetes. • In people with rs13333226-G, is associated with a slightly lower risk of hypertension and a 7.7% reduction per allele for risk of CV events. • In people with rs12917707-T, we see a 20% decreased risk of CKD • In people with rs1711437-A, their creatinine clearance is approximately that of someone who is 4–5 years younger.
  • 16. What Should Patients and Doctors Know • In general CKD is characterized by a gradual loss of the kidney’s filtration capacity. • Markers Don’t tell everything – Genetic variants found so far only account for 1.4% of variance seen in eGFR, and at most the relative risk for CKD is modified by 20% per loci.
  • 17. What Should Patients and Doctors Know • Genetic Risk does not translate into clinical risk – Complex interaction with environmental factors – Would need to calculate a likelihood ratio in conjunction with a probability of disease prevalence to gain a better estimate of clinical risk.
  • 18. What Should Patients and Doctors Know • Prevention – Keep diabetes and blood pressure controlled – If at risk perform screening tests – Reduce exposure to nephrotoxic drugs – Eat right and exercise – Know your family history • If you have a positive family history ask doctor to perform common screening tests for kidney function.
  • 19. TREATMENT • High blood pressure medications. People with kidney disease can have worsening high blood • pressure. Your doctor might recommend medications to lower your blood pressure — • commonly • angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers — and to • preserve kidney function. High blood pressure medications can initially decrease kidney function and change electrolyte • levels, so you might need frequent blood tests to monitor your condition. Your doctor may also • recommend • a water pill (diuretic) and a low-salt diet. • Medications to relieve swelling. People with chronic kidney disease often retain fluids. This can • lead • to swelling in the legs as well .as high blood pressure. Medications called diuretics can help • maintain • the balance of fluids in your body. • Medications to treat anemia. Supplements of the hormone erythropoietin , sometimes with • added iron, • help produce more red blood cells. This might relieve fatigue and weakness associated with • anemia. • Medications to lower cholesterol levels. Your doctor might recommend medications called • statins to • lower your cholesterol. People with chronic kidney disease often have high levels of bad • cholesterol, • which can increase the risk of heart disease
  • 20. Treatment for end-stage kidney disease If your kidneys can't keep up with waste and fluid clearance on their own and you develop complete or near-comple • Dialysis. Dialysis artificially removes waste products and extra fluid from your blood when your kidneys can n • longer do this. In hemodialysis, a machine filters waste and excess fluids from your blood. In peritoneal dialysis, a thin tube inserted into your abdomen fills your abdominal cavity with a dialysis • solution • that absorbs waste and excess fluids. After a time, the dialysis solution drains from your body, carrying the w • with it. • Kidney transplant. A kidney transplant involves surgically placing a healthy kidney from a donor into your • body. Transplanted kidneys can come from deceased or living donors. • Medications to protect your bones. Calcium and vitamin D supplements can help prevent weak bones and lo • your risk of fracture. You might also take medication known as a phosphate binder to lower the amount of • phosphate in your blood and protect your blood vessels from damage by calcium deposits (calcification). • A lower protein diet to minimize waste products in your blood. As your body processes protein from • foods, • it creates waste products that your kidneys must filter from your blood. To reduce the amount of work your kidn • must do, your doctor might recommend eating less protein. A registered dietitian can suggest ways to lower yo • protein intake while still eating a healthy diet
  • 21. Sources • Wheeler et al 2009. Sequential Use of Transcriptional Profiling, Expression Quantitative Trait Mapping, and Gene Association ImplicatesMMP20 in Human Kidney Aging. • Padmanabhan S et al. (2010) . “Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.”PLoS Genet. 6(10):e1001177. • Gudbjartsson DF et al. (2010) . “Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.” PLoS Genet. 6(7):e1001039. • Köttgen A et al. (2009) . “Multiple loci associated with indices of renal function and chronic kidney disease.” Nat. Genet. 41(6):712-7.

Editor's Notes

  1. Things that cause kidney disease: -Glomerulonephritis, a group of diseases that cause inflammation and damage to the kidney's filtering units. These disorders are the third most common type of kidney disease. -Inherited diseases, such as polycystic kidney disease, which causes large cysts to form in the kidneys and damage the surrounding tissue. -Malformations that occur as a baby develops in its mother's womb. For example, a narrowing may occur that prevents normal outflow of urine and causes urine to flow back up to the kidney. This causes infections and may damage the kidneys. -Lupus and other diseases that affect the body's immune system. -Obstructions caused by problems like kidney stones, tumors or an enlarged prostate gland in men. -Repeated urinary infections.
  2. The causes of acute or chronic kidney disease are traditionally classified by that portion of the renal anatomy most affected by the disorder The two major causes of reduced renal perfusion are volume depletion and/or relative hypotension. This may result from true hypoperfusion due to bleeding, gastrointestinal, urinary, or cutaneous losses, or to effective volume depletion in heart failure, shock, or cirrhosis Various vascular diseases can also lead to kidney disease. Direct etiologies from kidney: Tubular and interstitial disease, Glomerular disease, Obstructive uropathy Acute tubular necrosis — 45 percent Prerenal — 21 percent Acute or chronic kidney disease — 13 percent (mostly due to acute tubular necrosis and prerenal disease) Urinary tract obstruction — 10 percent (most often older men with prostatic disease) Glomerulonephritis or vasculitis — 4 percent Acute interstitial nephritis — 2 percent Atheroemboli — 1 percent
  3. _followed by American Indians and Alaska Natives, then Asian Americans and native Hawaiians and other Pacific Islanders, and finally Caucasians.
  4. -APOL1: Autosomal recessive pattern of inheritance and confer a substantially higher risk of ESRD (10-fold higher risk of ESRD due to focal glomerulosclerosis and 7-fold higher risk of ESRD attributed to hypertension. APOL1 mutations are found exclusively among individuals of African descent and, although speculative, are believed to provide resistance to disease causing trypanosomes. The functional significance of these gene variants is unclear, but they may lead to diminished expression of APOL1 in podocytes and inappropriate expression in renal arterioles Sources: APOL1: http://www.sciencemag.org.laneproxy.stanford.edu/content/329/5993/841.long “In aggregate, the 13 new renal function loci plus the three previously identified renal function loci account for 1.4% of the variation in eGFRcrea.” Similar to what has been observed previously, we identified modest effects of the risk alleles on eGFR and CKD. Taken together, these renal function loci are associated with 1.4% of the variation in eGFRcrea”
  5. Familial Juvenile hyperuricemic nephropathy type 1 Familial juvenile hyperuricemic nephropathy type 2 (FJHN2) is characterized by hypoproliferative anemia with low hemoglobin concentrations found in most affected children by age one year; hyperuricemia and gout found in most (not all) affected individuals; and slowly progressive chronic tubulo-interstitial kidney disease. Some affected children have polyuria (excessive urine production leading to frequent urination) and enuresis medullary cystic kidney disease type 2  inherited diseases with similar renal morphology characterized by bilateral small corticomedullary cysts in kidneys of normal or reduced size and tubulointerstitial sclerosis leading to end-stage renal disease (ESRD)
  6. Rs4293393: http://jasn.asnjournals.org/content/21/2/337.full -observed lower urinary uromodulin concentrations per each copy of the C allele at rs4293393 Rs12917707: http://www.nature.com/ng/journal/v41/n6/full/ng.377.html Rs13333226: http://www.ncbi.nlm.nih.gov/pubmed/21082022?dopt=Abstract
  7. Source: http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000326901